Dr. Eliano Navarese, of Nicolaus Copernicus University, Poland, discusses the results of a meta-analysis comparing coronary revascularization vs. medical therapy alone. The study, presented as a late-breaking trial at EuroPCR 2021, showed that the benefits of both approaches are additive and that their combination is needed to attain maximal and lasting prevention of adverse events.